The role of nonhuman primate models in AIDS vaccine development (Q33946205)

30 July 2017

1 reference

title

The role of nonhuman primate models in AIDS vaccine development (English)

1 reference

30 July 2017

Johnston MI

1

1 reference

30 July 2017

publication date

1 July 2000

1 reference

Trends in Molecular Medicine

30 July 2017

published in

1 reference

30 July 2017

volume

6

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

267-270

1 reference

Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Enumeration of lymphokine-secreting cells as a quantitative measure for cellular immune responses in rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Cytotoxic T lymphocytes specific for the simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

The construction and evaluation of SIV/HIV chimeras that express the envelope of European HIV type 1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develop AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV)

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Evaluation of a candidate human immunodeficiency virus type 1 (HIV-1) vaccine in macaques: effect of vaccination with HIV-1 gp120 on subsequent challenge with heterologous simian immunodeficiency virus-HIV-1 chimeric virus

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Protection from pathogenic SIV challenge using multigenic DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901724-X

7 January 2021

10.1016/S1357-4310(00)01724-X

Identifiers

DOI

1 reference

30 July 2017

1 reference